期刊名称：CURRENT COMPUTER-AIDED DRUG DESIGN
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.
Instructions to Authors
Instructions for Authors
Regular manuscripts may be submitted directly to the Editorial Office.
ONLINE MANUSCRIPT SUBMISSION: An online submission and tracking service via Internet facilitates a speedy and cost-effective submission of manuscripts. The full manuscript has to be submitted online via Bentham's Content Management System (CMS) at http://www.bentham-editorial.org/ View Instructions
Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The principal/corresponding author will be required to submit a Covering Letter along with the manuscript, on behalf of all the co-authors (if any). The author(s) will confirm that the manuscript (or any part of it) has not been published previously or is not under consideration for publication elsewhere. Furthermore, any illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained.
For all online submissions, please provide soft copies of all the materials (main text in MS Word or Tex/LaTeX), figures / illustrations in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files, while a PDF version of the entire manuscript must also be included, embedded with all the figures / illustrations / tables / chemical structures etc.
It is imperative that before submission, authors should carefully proofread the files for special characters, mathematical symbols, Greek letters, equations, tables, references and images, to ensure that they appear in proper format.
References, figures, tables, structures etc. should be referred to in the text at the place where they have been first discussed. Figures legends/captions should also be provided.
A successful electronic submission of a manuscript will be followed by a system-generated acknowledgement to the principal/corresponding author. Any queries therein should be addressed to madiha@benthamscience.org
MANUSCRIPTS PUBLISHED: The Journal accepts mini- and full-length review mini- and full-length review articles written in English. Single topic/thematic issues may also be considered for publication.
Single Topic Issues: These issues will be restricted to review articles. A Single Topic Special Editor will offer a short perspective and co-ordinate the solicitation of manuscripts between 3-5 (for a mini-hot topic) and 6-10 (for full- length hot topic) from leading scientists. Authors interested in editing a single topic issue in an emerging topic of drug design may submit their proposal to the Editor-in-Chief at cad@benthamscience.org for consideration. Visit http://www.bentham.org/ccadd/Special-Issues.htm for viewing forthcoming issues.
MANUSCRIPT LENGTH:
Review Articles: The maximum page length limit for comprehensive Review articles is fifty pages. For Mini-Review articles, the maximum page length is twenty five journal pages. Each journal page is on average 900 words.
There is no restriction on the number of figures, tables or additional files e.g. video clips, animation and datasets, that can be included with each article online. Authors should include all relevant supporting data with each article (Refer to Supplementary Material section).
MANUSCRIPT PREPARATION:
The manuscript should be written in English in a clear, direct and active style. All pages must be numbered sequentially, facilitating in the reviewing and editing of the manuscript.
For further convenience, the customer support team available at Bentham Publishing Services (www.benthampublishingservices.com) can provide assistance to authors for the preparation of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS: Manuscripts may be divided into the following sections:
Covering letter
Title
Title page
Abstract
Keywords
Text organization
List of abbreviations (if any)
Conflict of interest (if any)
Acknowledgements (if any)
References
Appendices
Figures/illustrations (if any)
Chemical structures (if any)
Tables and captions (if any)
Supportive/supplementary material (if any)
Covering Letter: It is mandatory that a signed covering letter also be submitted along with the manuscript by the author to whom correspondence is to be addressed, delineating the scope of the submitted article declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the 'Instructions for Authors'. All inconsistencies in the text and in the reference section, and any typographical errors must be carefully checked and corrected before the submission of the manuscript. The article contains no such material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the copyright agreement. The authors acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the copy right agreement. DOWNLOAD COVERING LETTER
Title: The title of the article should be precise and brief and must not be more than 120 characters. Authors should avoid the use of non-standard abbreviations. The title must be written in title case except for articles, conjunctions and prepositions.
Authors should also provide a running title? Title, running title, byline, correspondent footnote and key words should be written as presented in original manuscripts.
Title Page: Title page should include paper title, author(s) full name and affiliation, corresponding author(s) names complete affiliation/address, along with phone, fax and email.
Abstract: The abstract should not exceed 250 words for review papers summarizing the essential features of the article.
Keywords: Provide 6 to 8 keywords in alphabetical order.
Text Organization: The main text should begin on a separate page and should be divided into separate sections. The manuscript should be divided into title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed, which should be followed by the Acknowledgement (if any) and Reference sections. The review article should mention any previous old and recent important reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments. The authors should avoid presenting material which has already been published in a previous review. The authors are advised to present and discuss their observations in brief. The manuscript style must be uniform throughout the text and 10 pt Times New Roman fonts should be used. The full term for an abbreviation should precede its first appearance in the text unless it is a standard unit of measurement. The reference numbers should be given in square brackets in the text. Italics should be used for Binomial names of organisms (Genus and Species), for emphasis and for unfamiliar words or phrases. Non-assimilated words from Latin or other languages should also be italicized e.g. per se, et al. etc.
Greek Symbols and Special Characters: Greek symbols and special characters often undergo formatting changes and get corrupted or lost during preparation of manuscript for publication. To ensure that all special characters used are embedded in the text, these special characters should be inserted as a symbol but should not be a result of any format styling (Symbol font face) otherwise they will be lost during conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These guidelines provide a set of recommendations comprising a list of items relevant to their specific research design. Chemical equations, chemical names, mathematical usage, unit of measurements, chemical and physical quantity & units must conform to SI and Chemical Abstracts or IUPAC.
All kinds of measurements should be reported only in International System of Units (SI).
List of Abbreviations: If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided.
Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
Acknowledgements: Please acknowledge anyone (individual/company/institution) who has contributed to the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section.
This journal complies with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals http://www.icmje.org and the FDA's Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices http://www.fda.gov/oc/op/goodreprint.html
References: References must be listed in the ACS Style only. All references should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section. The reference numbers must be finalized and the bibliography must be fully formatted before submission.
See below few examples of references listed in the ACS Style:
Journal Reference:
[1] Bard, M.; Woods, R.A.; Bartón, D.H.; Corrie, J.E.; Widdowson, D.A. Sterol mutants of Saccharomyces cerevisiae: chromatographic analyses. Lipids, 1977, 12(8), 645-654.
[2] Zhang, W.; Brombosz, S.M.; Mendoza, J.L.; Moore, J.S. A high-yield, one-step synthesis of o-phenylene ethynylene cyclic trimer via precipitation-driven alkyne metathesis. J. Org. Chem., 2005, 70, 10198-10201.
Book Reference:
[3] Crabtree, R.H. The Organometallic Chemistry of the Transition Metals, 3rd ed.; Wiley & Sons: New York, 2001.
Book Chapter Reference:
[4] Wheeler, D.M.S.; Wheeler, M.M. In: Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier Science B. V: Amsterdam, 1994; Vol. 14, pp. 3-46.
Conference Proceedings:
[5] Jakeman, D.L.; Withers, S.G. E. In: Carbohydrate Bioengineering: Interdisciplinary Approaches, Proceedings of the 4th Carbohydrate Bioengineering Meeting, Stockholm, Sweden, June 10-13, 2001; Teeri, T.T.; Svensson, B.; Gilbert, H.J.; Feizi, T., Eds.; Royal Society of Chemistry: Cambridge, UK, 2002; pp. 3-8.
URL(WebPage):
[6] National Library of Medicine. Specialized Information Services: Toxicology and Environmental Health. http://sis.nlm.nih.gov/Tox/ToxMain.html (Accessed May 23, 2004)
Patent:
[7] Hoch, J.A.; Huang, S. Screening methods for the identification of novel antibiotics. U.S. Patent 6,043,045, March 28, 2000.
Thesis:
[8] Mackel, H. Capturing the Spectra of Silicon Solar Cells. PhD Thesis, The Australian National University: Canberra, December 2004.
E-citations:
[9] Citations for articles/material published exclusively online or in open access (free-to-view) , must contain the exact Web addresses (URLs) at the end of the reference(s), except those posted on an author's Web site unless editorially essential, e.g. Reference: Available from: URL?
Editorial Board
Editorial Board
Editor-in-Chief:
Satya P. Gupta
Meerut Institute of Engineering and Technology
Meerut
India
Editor for Europe:
Darren R. Flower
The Jenner Institute
UK
Editor for North America:
Alan C. Rigby
Harvard Medical School
USA
Section Editor:
Sanjay Srivastava
AstraZeneca R&D
Canada
Editorial Advisory Board:
E. Aki-Sener (Ankara University, Ankara, Turkey)
A.M. Almerico (Università degli Studi di Palermo, Palermo, Italy)
A.T. Balaban (Texas A&M University at Galveston, Galveston, TX, USA)
K. Balasubramanian (Lawrence Livermore National Lab & California State University East Bay, Hayward, CA, USA)
S. Balaz (North Dakota State University, Fargo, ND, USA)
S. Basak (University of Minnesota, Duluth, MN, USA)
R. Benigni (Istituto Superiore di Sanita', Rome, Italy)
P.V. Bharatam (National Institute of Pharmaceutical Education and Research, Mohali, India)
M. Botta (Università degli Studi di Siena, Siena, Italy)
M. Brewer (Evotec, Didcot, UK)
G. Bulusu (Tata Consultancy Services, Hyderabad, India)
M. Charton (Pratt Institute, Brooklyn, NY, USA)
J.R. Chretien (Centre d'Innovation, Orleans, France)
D.A. Cirovic (Sanofi Aventis, Bridgewater, NJ, USA)
L. David (AstraZeneca Lundbeck, Valby, Denmark)
M. Davies (University of London, London, UK)
R.B. De Alencastro (Instituto de Quimica da UFRJ, Rio de Janeiro, Brazil)
A.K. Debnath (New York Blood Center, New York, NY, USA)
D.J. Diller (Wyeth Research, Princeton, NJ, USA)
I. Doytchinova (Medical University, Sofia, Bulgaria)
G. Ecker (University of Vienna, Wien, Austria)
J. Erickson (Lilly Research Laboratories, Indianapolis, IN, USA)
R. Garg (San Diego State University, San Diego, CA, USA)
A.C. Gibbs (Johnson & Johnson Pharmaceutical Research & Development, Cranbury, NJ, USA)
M. Gromiha (Computational Biology Research Center, AIST, Tokyo, Japan)
C.R. Groom (UCB, Cambridge, UK)
K. Gundertofte (Computational Chemistry, Lundbeck, Denmark)
S. Hannongbua (Kasetsart University, Bangkok, Thailand)
C. Hansch (Pomona College, Claremont, CA, USA)
C. Hattotuwagama (GlaxoSmithKline PLC, Stevenage, UK)
Q.-Y. He (Jinan University, Guangzhou, China)
A.R. Katritzky (University of Florida, Gainesville, FL, USA)
L.B. Kier (Virginia Common Wealth University, Richmond, VA, USA)
G. Klopman (Case Western Reserve University, Beachwood, OH, USA)
H. Kubinyi (University of Heidelberg, Weisenheim am Sand, Germany)
M. Kuchar (Res. Inst. for Pharm. and Biochem., Praha, Czech Republic)
R. Lewis (Novartis, Basel, Switzerland)
D.J. Livingstone (Chem Quest, Sandown, UK)
J.M. Luco (Universidad Nacional de San Luis, San Luis, Argentina)
P.P. Mager (University of Leipzig, Leipzig, Germany)
G. Maggiora (University of Arizona, Tucson, AZ, USA)
R. Mannhold (Heinrich-Heine-Universitat, Dusseldorf, Germany)
Y. Mizushina (Kobe-Gakuin University, Hyogo, Japan)
S.H. Nilar (Novartis Institute for Tropical Disease, Singapore, Singapore)
Y.S. Prabhakar (Central Drug Research Institute, Lucknow, India)
M.J. Ramos (Universidade do Porto, Porto, Portugal)
M. Randic (Drake University, Des Moines, IA, USA)
P.A. Reche (Laboratorio de ImmunoMedicina, Madrid, Spain)
D. Rognan (CNRS, Strasbourg, France)
E. Schönbrunn (University of South Florida, Tampa, FL, USA)
P.G. Seybold (Wright State University, Dayton, OH, USA)
K. Shanmugasundaram (Harvard University, Boston, MA, USA)
W. Sippl (University of Halle, Halle, Germany)
A. Stevens (KuDOS Pharm. Ltd., Horsham, UK)
T. Sulea (National Research Council of Canada, Montreal, Canada)
H. Sun (DoD Biotechnology HPC Software Applications Institute, Frederick, MD, USA)
A. Tropsha (University of North Carolina, Chapel Hill, NC, USA)
J.H. Van Drie (Novartis Institutes for BioMedical Research, Cambridge, MA, USA)
A.V. Veselovsky (V.N. Orekhovich Institute of Biomedical Chemistry, Moscow, Russia)
H.O. Villar (Altoris Inc., La Jolla, CA, USA)
B.O. Villoutreix (Inserm U648, University of Paris, Paris, France)
S.R. Voleti (Ranbaxy Laboratories Ltd., Guragon, India)
R. Wang (Shanghai Institute of Organic Chemistry, Shanghai, China)
D.F. Weaver (Dalhousie University, Halifax, Canada)
H.-Y. Zhang (Huazhong Agricultural University, Wuhan, China)
M. Zou (University of Oklahoma Health Science Center, Oklahoma City, OK, USA)
X. Zou (University of Missouri, Columbia, MO, USA)
| 
